Report: Stimatix Acquired By German Company For $10-15M

December 21, 2014 | According to a “Calcalist” report, the Israeli medical device company Stimatix was acquired for $10-15 million by a German medical device company. Stimatix develops medical products to aid patients with intestinal blockage or Crohn’s Disease. Last year, Stimatix received US Food & Drug Administration approval for the distribution of their products, reaching primary profits in the millions of dollars. Stimatix was founded in 2009 by Shai Greenburg and Meir Or.